Valeant Pharmaceuticals International Inc (VRX)

10.71
NYSE : Health Care
Prev Close 10.71
Day Low/High 0.00 / 0.00
52 Wk Low/High 10.35 / 38.50
Avg Volume 19.04M
Exchange NYSE
Shares Outstanding 347.84M
Market Cap 3.73B
EPS -6.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Chipotle, Herbalife, Sears: Doug Kass' Views

Chipotle, Herbalife, Sears: Doug Kass' Views

Doug Kass shares his thoughts on Pershing Square, and talks about Sears.

10 Things We Learned From Our Daily Facebook Show With Jim Cramer

10 Things We Learned From Our Daily Facebook Show With Jim Cramer

TheStreet's Jim Cramer discusses the hottest stocks of the day on our daily Facebook Live show, airing weekdays at 10 a.m. EST.

Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?

Why Are So Many Employees Selling Stock Options - And Is That Really a Good Idea?

A new study shows U.S. employees love their employee stocks and stock options, and like to exercise them early and often.

How to Deal With the Trader's Dilemma

How to Deal With the Trader's Dilemma

Managing risk requires accepting that you'll be wrong sometimes and planning accordingly; just ask Bill Ackman.

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Closing Bell: Citi Dumps SeaWorld; U.S. Stocks Churn as Health Care Falls

Stocks churn around the flatline to end the week as a selloff in health care counters gains seen elsewhere.

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Broad Gains Overshadow Health Care Losses to Boost Wall Street

Stocks rise on Friday even as a selloff in health care extends into its second day.

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks Creep Lower as Health Care Selloff Extends Into Day 2

Stocks creep lower on Friday as a selloff in health care extends into its second day.

This Key Measure Shows the S&P Could Be Headed for a 5% Pullback

This Key Measure Shows the S&P Could Be Headed for a 5% Pullback

Oil and natural gas prices are on the downswing and one key measure seems to pointing that we could be nearing a pullback in the S&P.

Stock Futures Mixed as Crude Rises, G-20 Summit Kicks Off

Stock Futures Mixed as Crude Rises, G-20 Summit Kicks Off

Stock futures move mostly higher on Friday as crude oil attempts another rebound to close out the week.

Valeant Shares Skyrocket After Hours on ValueAct Buy

Valeant Shares Skyrocket After Hours on ValueAct Buy

The move comes just days after Bill Ackman's Pershing Square exited the stock.

Jim Cramer on Ackman's Valeant Loss: He Will Be Back

Jim Cramer on Ackman's Valeant Loss: He Will Be Back

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is confident hedge fund manager Bill Ackman will rebound from his multi-billion dollar loss in Valeant Pharmaceuticals.

A Quick Update on Our Valeant Pharmaceuticals Trade

We have repurchased the short March 17 puts this morning, while selling a March 17 $12 call, to ensure it will be in the black and keep more upside on the table.

Trader's Daily Notebook: Would Somebody Please Change the Channel?

Trader's Daily Notebook: Would Somebody Please Change the Channel?

Most traders will probably wait for the Fed-related dust to settle.

Apple, Facebook and Tesla: Off the Charts

Apple, Facebook and Tesla: Off the Charts

Carolyn Boroden charts Facebook, Apple and Tesla: Here's how tracking 5- and 13-day exponential moving averages can keep you out of the red.

Nucor: Cramer's Top Takeaways

Nucor: Cramer's Top Takeaways

John Ferriola, CEO of Nucor, tells Jim Cramer that 2017 is shaping up to be better than 2016.

Prologis: Cramer's Top Takeaways

Prologis: Cramer's Top Takeaways

Hamid Moghadam, CEO of Prologis, tells Jim Cramer that if you believe ecommerce will continue to grow, so will his company.

12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)

12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)

Jim Cramer says it's his job to educate and entertain you, as well as help you make and save money.

Cisco Systems, CyberArk, Check Point Software: 'Mad Money' Lightning Round

Cisco Systems, CyberArk, Check Point Software: 'Mad Money' Lightning Round

Jim Cramer is bullish on Cisco Systems, Check Point Software and CyberArk Software.

Cramer: Is it Time to Buy Valeant?

Cramer: Is it Time to Buy Valeant?

On an inconsistent day in the markets, some ask if now's the time to buy Valeant.

Wild Weather Mutes Activity in a Down Day for Wall Street

Wild Weather Mutes Activity in a Down Day for Wall Street

The weather was wild on Wall Street, but it was a lot quieter indoors where low volume made for a muted day of trading.

Valeant Shares Still Reeling From Ackman Exit

Valeant Shares Still Reeling From Ackman Exit

Bill Ackman's Pershing Square took a $2.8 billion loss on the investment.

Novice Trade: Valeant Pharmaceuticals

Novice Trade: Valeant Pharmaceuticals

This trade is highly risky but with a really good reward.

Chipotle Will Require Ackman-Like Patience

Chipotle Will Require Ackman-Like Patience

CMG is stuck in a sideways trend.

Bill Ackman Exits Valeant

Bill Ackman Exits Valeant

Pershing Square held a 10% long position in Valeant Pharmaceuticals International Inc.

Stocks Hold Lower as Blizzard Conditions Stifle Activity, Crude Pressures Energy Names

Stocks Hold Lower as Blizzard Conditions Stifle Activity, Crude Pressures Energy Names

Stocks fall Tuesday in low-volume trading as blizzard conditions stifle activity on Wall Street.

All the Talk Is of Ackman and Valeant

All the Talk Is of Ackman and Valeant

Ackman's VRX trade shows how difficult it is to be consistently disciplined.

Chipotle Will Require Ackman-Like Patience

Chipotle Will Require Ackman-Like Patience

CMG is stuck in a sideways trend.